Durability of Response After DAA Therapies - Fabien Zoulim, MD, PhD

International Workshop on HBV Cure 2023

Does siRNA Restore Host Control and Could it Lead to Sustained HBsAg Suppression? - Michael J. Sofia, PhD

International Workshop on HBV Cure 2023

Discrimination of Integrated vs. cccDNA Derived HBsAg - Chloe Thio, MD

International Workshop on HBV Cure 2023

Bepirovirsen in Combination with Peg-IFN and Other Molecules - Stuart Kendrick, MD, PhD, MRCP

International Workshop on HBV Cure 2023

Balance of Response and Adverse Events in Immunotherapy for CHB - Jordan Feld, MD, MPH

International Workshop on HBV Cure 2023

Are We Only Able to Suppress HDV or is Cure in Reach? - Pietro Lampertico, MD, PhD

International Workshop on HBV Cure 2023

Anti-HBs Monoclonal Antibodes in Nuc-naïve and Combo Therapies - Carey Hwang, MD, PhD

International Workshop on HBV Cure 2023

How Did the Health Disaster Lead to a Major Social and Economic Crisis? - Helena Legido-Quigley

Lessons Learned from the Pandemic 2023: Redesigning Clinical Care, Research, and Public Health

Chomi: a Survivor-centric, Multilingual Gender-based Violence (GBV) Chatbot Leveraging Technology to Increase Access to GBV Information and Support Services - Cristianne Wendler

International Workshop on HIV & Adolescence 2023

A community-based peer-to-peer psychological and social support model to improve retention in care among Cameroonian adolescents perinatally infected with Human Immunodeficiency Virus - Ateba Ndongo Francis

International Workshop on HIV & Adolescence 2023

Side Effects of Oral Antiviral Therapy for COVID: Patient Education - Jeremiah Olivas, MSN, AG-ACNP

COVID-19 Clinical Forum for Pharmacists and Nurses 2023

Real-life Management of DDIs in Complex Clinical Cases - Pierre Giguère, BSc, MSc

COVID-19 Clinical Forum for Pharmacists and Nurses 2023

Complexities and Considerations for Drug-drug Interactions of Oral Antivirals for COVID-19 - Erin McCreary, PharmD, BCPS, BCIDP

COVID-19 Clinical Forum for Pharmacists and Nurses 2023

Future Study of GP120 Inhibitors as Potential Immunomodulators in Clinical Care - C. Ní Cheallaigh, MB, BAO, BCh, MRCP, PhD

EACS 2023 Symposium - The Devil Wears GP120

Depression Triggers in Adolescents and Young Women in the DREAMS Program - Linah K Mwango.pdf

International Workshop on HIV & Adolescence 2023

Designing Innovative HIV Prevention Interventions That Are Acceptable to Adolescents in Sub-Saharan Africa... - MaryJane Ijeoma Nweje.pdf

International Workshop on HIV & Adolescence 2023

Bridging the Gap for Adolescents_Enhancing Access to SRH Products and HIV Prevention - Wawira Nyagah.pdf

International Workshop on HIV & Adolescence 2023

HIV Testing, PrEP Awareness, PrEP Uptake and Correlates Among Adolescent Men Who Have Sex With Men in Vietnam - Minh Nguyen.pdf

International Workshop on HIV & Adolescence 2023

Integrating Oral and Mental Health with HIV and SRHR Care for Adolescents in Nigeria - Morenike Oluwatoyin Folayan.pdf

International Workshop on HIV & Adolescence 2023

Integrating Gender-affirming Care into Prevention and Treatment of HIV & STIs - Madeleine Muller.pdf

International Workshop on HIV & Adolescence 2023

Missed Opportunities for PrEPUptake Among Adolescent Girls and Young Women Who Are Mothers at Risk of HIV in South Africa - Jenny Chen-Charles.pdf

International Workshop on HIV & Adolescence 2023

Prevalence and Factors Associated With Risky Sexual Behaviours Among Female Adolescents in Zambia - Daniel Mwamba.pdf

International Workshop on HIV & Adolescence 2023

Social Protection as an Intervention for Preventing HIV Risk Among Young People in Southern African Countries - Silinganisiwe Dzumbunu.pdf

International Workshop on HIV & Adolescence 2023

Risks, Rights, and Multi-Sectoral Responses_Advancing SRHR for Adolescents - Mona Ibrahim.pdf

International Workshop on HIV & Adolescence 2023